Effamall Insights More
      Tigermed Consulting Reports Net Profits of RMB 888 Million in 2025, Up 119.15% Year-on-Year
      Tigermed Consulting Reports Net Profits of RMB 888 Million in 2025, Up 119.15% Year-on-Year
      Enterprise News 04-29 18:15
      Jingxin Pharmaceutical Reports Net Profits of RMB 758 Million in 2025, Up 6.46% Year-on-Year
      Jingxin Pharmaceutical Reports Net Profits of RMB 758 Million in 2025, Up 6.46% Year-on-Year
      Enterprise News 04-29 18:14
      ShengDa Biological Pharmaceutical Reports Net Profits of RMB 62.16 Million in 2025, Up 111.24% Year-on-Year
      ShengDa Biological Pharmaceutical Reports Net Profits of RMB 62.16 Million in 2025, Up 111.24% Year-on-Year
      Enterprise News 04-29 18:13
      Tianxin Pharmaceutical Reports Net Profits of RMB 592 Million in 2025, Down 9.16% Year-on-Year
      Tianxin Pharmaceutical Reports Net Profits of RMB 592 Million in 2025, Down 9.16% Year-on-Year
      Enterprise News 04-29 18:10
      Wens Foodstuff Group Reports Net Profits of RMB 5.266 Billion in 2025
      Wens Foodstuff Group Reports Net Profits of RMB 5.266 Billion in 2025
      Enterprise News 04-29 18:09
      Brother Enterprises Holding Reports Net Profits of RMB 95.11 Million in 2025, Up 133.02% Year-on-Year
      Brother Enterprises Holding Reports Net Profits of RMB 95.11 Million in 2025, Up 133.02% Year-on-Year
      Enterprise News 04-29 18:08
      Guangji Pharmaceutical Reports a Net Loss of RMB 404 Million in 2025
      Guangji Pharmaceutical Reports a Net Loss of RMB 404 Million in 2025
      Enterprise News 04-29 18:04
      Haid Group Reports Net Profits of RMB 4.28 Billion in 2025, Down 4.97% Year-on-Year
      Haid Group Reports Net Profits of RMB 4.28 Billion in 2025, Down 4.97% Year-on-Year
      Enterprise News 04-29 18:03
      Nanjing Red Sun Reports a Net Loss of RMB 379 Million in 2025
      Nanjing Red Sun Reports a Net Loss of RMB 379 Million in 2025
      Enterprise News 04-29 18:01
      Yifan Pharmaceutical Reports Net Profits of RMB 402 Million in 2025, Up 4.16% Year-on-Year
      Yifan Pharmaceutical Reports Net Profits of RMB 402 Million in 2025, Up 4.16% Year-on-Year
      Enterprise News 04-29 18:00
        All Type
        Loading...
        Loading...